造血器腫瘍患者に対するがん化学療法において薬学的ケアがもたらす医療経済学的効果

概要

論文の詳細を見る
The aim of this study was to clarify the effects of pharmaceutical care on direct expenses in cancer chemotherapy, i.e. medicine costs, medical service fees, and medical treatment payments. To do this, 35 patients at the Social Insurance Kyoto Hospital were surveyed from March to August 2005. All of the subjects were suffering from hematological malignant diseases, and receiving pharmaceutical care from a pharmacist. There were 27 instances (14 patients) of prescription changes through clinical pharmacy interventions, causing an increase of \1,786/day in the mean cost of medicines for supportive therapy. However, when the medical service fees were examined using the Diagnosis Procedure Combination (DPC) we estimated that the prevention of adverse reactions by the prescription changes reduced medical costs by 4,732,360-yen. These findings implied that the increase in medicine costs of \51/patient led to a reduction of \135,210/patient in medical service fees, suggesting that pharmaceutical care was both effective and relatively low in cost. The cost of pharmaceutical care was estimated to be \592,000 per pharmacist. In cancer chemotherapy, pharmaceutical care had a beneficial effect on direct expenses for chemotherapy, i.e. medicine costs, medical service fees, and medical treatment payments. It was therefore effective in clinical terms as well as with regard to medical economics.
日本医療薬学会の論文
2008-12-10